Literature DB >> 24937074

Toll-like receptor 4 is essential to preserving cardiac function and survival in low-grade polymicrobial sepsis.

Ming Zhang1, Lin Zou, Yan Feng, Yu-Jung Chen, Qichang Zhou, Fumito Ichinose, Wei Chao.   

Abstract

BACKGROUND: Toll-like receptor 4 (TLR4), the receptor for endotoxin, mediates hyperinflammatory response and contributes to high mortality during both endotoxin shock and severe sepsis. However, little is known about the role of TLR4 in the pathogenesis of low-grade polymicrobial sepsis, which is often associated with immunosuppression.
METHODS: Low-grade polymicrobial sepsis was generated by cecum ligation and puncture. Mortality was monitored in wild- type (C57BL/10ScSn) and TLR4def (C57BL/10ScCr) mice. Ex vivo heart and individual cardiomyocyte function were assessed in Langendorff (Hugo Sachs Elektronik; Harvard Apparatus, Holliston, MA) and IonOptix systems (IonOptix, Milton, MA), respectively. Serum chemistry was tested for liver and kidney injury. Cytokines were examined using a multiplex immunoassay. Neutrophil migratory and phagocytic functions were assessed using flow cytometry. Reactive oxygen species were measured using redox-sensitive dichlorodihydrofluorescein dye.
RESULTS: Following cecum ligation and puncture, wild-type mice developed bacterial peritonitis with mild cardiac dysfunction (n=3 in sham and n=8 in cecum ligation and puncture) and a mortality of 23% within 14 days (n=22). In comparison, septic TLR4def mice had deleterious cardiac dysfunction (n=6 in sham and n=10 in cecum ligation and puncture), kidney and liver injury (n=7), and much higher mortality at 81% (n=21). The deleterious effects observed in septic TLR4def mice were associated with increased local and systemic cytokine response, reduced neutrophil migratory and phagocytic function, increased reactive oxygen species generation in leukocytes, and impaired bacterial clearance.
CONCLUSION: TLR4 plays an essential role in host defense against low-grade polymicrobial sepsis by mediating neutrophil migratory/phagocytic functions, attenuating inflammation, reducing reactive oxygen species generation, and enhanced bacterial clearance.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24937074      PMCID: PMC4237617          DOI: 10.1097/ALN.0000000000000337

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  49 in total

Review 1.  Toll-like receptor signalling.

Authors:  Shizuo Akira; Kiyoshi Takeda
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

2.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

3.  The epidemiology of sepsis in the United States from 1979 through 2000.

Authors:  Greg S Martin; David M Mannino; Stephanie Eaton; Marc Moss
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

4.  Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors.

Authors:  Jie Fan; Asrar B Malik
Journal:  Nat Med       Date:  2003-02-18       Impact factor: 53.440

5.  Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span.

Authors:  Ian Sabroe; Lynne R Prince; Elizabeth C Jones; Malcolm J Horsburgh; Simon J Foster; Stefanie N Vogel; Steven K Dower; Moira K B Whyte
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

6.  Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4.

Authors:  Thierry Roger; Céline Froidevaux; Didier Le Roy; Marlies Knaup Reymond; Anne-Laure Chanson; Davide Mauri; Kim Burns; Beat Michel Riederer; Shizuo Akira; Thierry Calandra
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-30       Impact factor: 11.205

7.  IRAK1 deletion disrupts cardiac Toll/IL-1 signaling and protects against contractile dysfunction.

Authors:  James A Thomas; Sandra B Haudek; Tolga Koroglu; May F Tsen; Debora D Bryant; D Jean White; Donna F Kusewitt; Jureta W Horton; Brett P Giroir
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-08       Impact factor: 4.733

8.  Immune cell Toll-like receptor 4 is required for cardiac myocyte impairment during endotoxemia.

Authors:  Samantha A Tavener; Elizabeth M Long; Stephen M Robbins; Krista M McRae; Holly Van Remmen; Paul Kubes
Journal:  Circ Res       Date:  2004-09-09       Impact factor: 17.367

9.  Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock.

Authors:  Nazima Pathan; Cheryl A Hemingway; Ash A Alizadeh; Alick C Stephens; Jennifer C Boldrick; Emmanuelle E Oragui; Colm McCabe; Steven B Welch; Adeline Whitney; Peter O'Gara; Simon Nadel; David A Relman; Sian E Harding; Michael Levin
Journal:  Lancet       Date:  2004-01-17       Impact factor: 79.321

10.  Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts.

Authors:  J M Brown; M A Grosso; L S Terada; G J Whitman; A Banerjee; C W White; A H Harken; J E Repine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more
  17 in total

1.  C23, an oligopeptide derived from cold-inducible RNA-binding protein, suppresses inflammation and reduces lung injury in neonatal sepsis.

Authors:  Naomi-Liza Denning; Weng-Lang Yang; Laura Hansen; Jose Prince; Ping Wang
Journal:  J Pediatr Surg       Date:  2019-01-04       Impact factor: 2.545

2.  Sex-specific differences in cardiac function, inflammation and injury during early polymicrobial sepsis.

Authors:  Sophie L M Walker; Chand Muthoo; Jenifer Sanchez; Ana Gutierrez Del Arroyo; Gareth L Ackland
Journal:  Intensive Care Med Exp       Date:  2022-06-20

3.  Toll-like receptor 4-induced ryanodine receptor 2 oxidation and sarcoplasmic reticulum Ca2+ leakage promote cardiac contractile dysfunction in sepsis.

Authors:  Jie Yang; Rui Zhang; Xin Jiang; Jingzhang Lv; Ying Li; Hongyu Ye; Wenjuan Liu; Gang Wang; Cuicui Zhang; Na Zheng; Ming Dong; Yan Wang; Peiya Chen; Kumar Santosh; Yong Jiang; Jie Liu
Journal:  J Biol Chem       Date:  2017-11-17       Impact factor: 5.157

4.  Experimental Study of the Protective Effect of Simvastatin on Lung Injury in Rats with Sepsis.

Authors:  Yu Wang; Wenping Yang; Xin Zhao; Rong Zhang
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

Review 5.  Targeting Toll-Like Receptors in Sepsis: From Bench to Clinical Trials.

Authors:  Fengqian Chen; Lin Zou; Brittney Williams; Wei Chao
Journal:  Antioxid Redox Signal       Date:  2021-04-07       Impact factor: 8.401

6.  The role of myeloid differentiation factor 88 on mitochondrial dysfunction of peritoneal leukocytes during polymicrobial sepsis.

Authors:  Yu Gong; Lin Zou; Dunjin Chen; Wei Chao
Journal:  Cent Eur J Immunol       Date:  2016-07-15       Impact factor: 2.085

7.  Blockade of Thrombopoietin Reduces Organ Damage in Experimental Endotoxemia and Polymicrobial Sepsis.

Authors:  Alessandra Cuccurullo; Elisabetta Greco; Enrico Lupia; Paolo De Giuli; Ornella Bosco; Erica Martin-Conte; Tiziana Spatola; Emilia Turco; Giuseppe Montrucchio
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

8.  A cold-inducible RNA-binding protein (CIRP)-derived peptide attenuates inflammation and organ injury in septic mice.

Authors:  Fangming Zhang; Max Brenner; Weng-Lang Yang; Ping Wang
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

9.  miR-25 inhibits sepsis-induced cardiomyocyte apoptosis by targetting PTEN.

Authors:  Yulong Yao; Fangyuan Sun; Ming Lei
Journal:  Biosci Rep       Date:  2018-04-13       Impact factor: 3.840

10.  Anti-inflammatory effects of microRNA-223 on sepsis-induced lung injury in rats by targeting the Toll-like receptor signaling pathway.

Authors:  Xuena Ma; Dan Tian; Weina Lv; Baoyu Gao; Zhiyong Ma; Xiaotuo Zheng
Journal:  Exp Ther Med       Date:  2021-07-07       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.